Class information for:
Level 1: CD3 ZETA//ORAL BIOL ORAL MED//ZETA CHAIN

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
21929 343 46.0 88%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
151 22214 IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CD3 ZETA Author keyword 6 33% 4% 15
2 ORAL BIOL ORAL MED Address 4 42% 2% 8
3 ZETA CHAIN Author keyword 4 31% 3% 11
4 ZETA CHAIN EXPRESSION Author keyword 3 100% 1% 3
5 TCR ZETA Author keyword 3 38% 2% 6
6 SERV CLIN 3 Address 3 60% 1% 3
7 BIOL CELULAR MOL FABIO Address 2 67% 1% 2
8 IMMUNE GENETHER Y Address 2 67% 1% 2
9 MAC 1 CELL Author keyword 2 67% 1% 2
10 JANE JERRY WEINTRAUB RECONSTRUCT BIOTECHNOL Address 2 11% 4% 14

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 CD3 ZETA 6 33% 4% 15 Search CD3+ZETA Search CD3+ZETA
2 ZETA CHAIN 4 31% 3% 11 Search ZETA+CHAIN Search ZETA+CHAIN
3 ZETA CHAIN EXPRESSION 3 100% 1% 3 Search ZETA+CHAIN+EXPRESSION Search ZETA+CHAIN+EXPRESSION
4 TCR ZETA 3 38% 2% 6 Search TCR+ZETA Search TCR+ZETA
5 MAC 1 CELL 2 67% 1% 2 Search MAC+1+CELL Search MAC+1+CELL
6 CD3ZETA 1 100% 1% 2 Search CD3ZETA Search CD3ZETA
7 INTRACELLULAR CYTOKINE ANALYSIS 1 50% 1% 2 Search INTRACELLULAR+CYTOKINE+ANALYSIS Search INTRACELLULAR+CYTOKINE+ANALYSIS
8 OSCSCS 1 100% 1% 2 Search OSCSCS Search OSCSCS
9 REGULATORY NK 1 100% 1% 2 Search REGULATORY+NK Search REGULATORY+NK
10 CD3 ZETA CHAIN 1 29% 1% 4 Search CD3+ZETA+CHAIN Search CD3+ZETA+CHAIN

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SIGNAL TRANSDUCTION MOLECULES 30 53% 11% 39
2 TRANSDUCTION MOLECULES 6 80% 1% 4
3 TUMOR ASSOCIATED LYMPHOCYTES 6 71% 1% 5
4 EVEN THOUGH 6 100% 1% 4
5 SIGNAL TRANSDUCING MOLECULES 4 36% 3% 9
6 ZETA CHAIN EXPRESSION 4 31% 3% 10
7 RECEPTOR ZETA CHAIN 3 12% 7% 25
8 ORAL CARCINOMA 3 24% 3% 11
9 ENDOGENOUS TNF ALPHA 2 40% 1% 4
10 CD3 ZETA CHAIN 2 16% 3% 9

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Down-regulation of zeta-chain expression in T cells: a biomarker of prognosis in cancer? 2004 85 63 56%
Immune suppression in cancer: Effects on immune cells, mechanisms and future therapeutic intervention 2006 192 93 28%
Dual Functions of Natural Killer Cells in Selection and Differentiation of Stem Cells; Role in Regulation of Inflammation and Regeneration of Tissues 2013 11 61 41%
Tumor Induced Inactivation of Natural Killer Cell Cytotoxic Function; Implication in Growth, Expansion and Differentiation of Cancer Stem Cells 2011 13 116 23%
Natural Killer Cells Preferentially Target Cancer Stem Cells; Role of Monocytes in Protection Against NK Cell Mediated Lysis of Cancer Stem Cells 2012 10 103 27%
Chronic inflammation, immunosuppression and cancer: New insights and outlook 2006 58 89 21%
Potential rescue, survival and differentiation of cancer stem cells and primary non-transformed stem cells by monocyte-induced split anergy in natural killer cells 2012 1 60 42%
Effective immunotherapy against cancer - A question of overcoming immune suppression and immune escape? 2004 91 154 10%
Tumor-Induced CD8+T-Cell Dysfunction in Lung Cancer Patients 2012 12 112 11%
Natural killer cells as effectors of selection and differentiation of stem cells: Role in resolution of inflammation 2014 0 57 33%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ORAL BIOL ORAL MED 4 42% 2.3% 8
2 SERV CLIN 3 3 60% 0.9% 3
3 BIOL CELULAR MOL FABIO 2 67% 0.6% 2
4 IMMUNE GENETHER Y 2 67% 0.6% 2
5 JANE JERRY WEINTRAUB RECONSTRUCT BIOTECHNOL 2 11% 4.1% 14
6 MID KENT CANC 1 100% 0.6% 2
7 MED ONCOL IMMUNOTHER Y GRP 1 33% 0.6% 2
8 CELLULAR PROD 1 50% 0.3% 1
9 EXPTL THER EUT PROGRAM 1 50% 0.3% 1
10 GENE THER Y MED 1 50% 0.3% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000246941 TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//AUTOLYMPHOCYTE THERAPY
2 0.0000242324 CELLULAR INJURY//TCR ZETA CHAIN//CD3 GAMMA
3 0.0000182106 IMMUNE SUPPRESSOR CELLS//IRX 2//SERV 151Z2
4 0.0000156900 UNITA OPERAT ASSISTENZIALE GINECOL ONCOL//CD1A//CDLA
5 0.0000137382 MHC NONRESTRICTED CYTOTOXICITY//HISTAMINE DIHYDROCHLORIDE//BOWYER ONCOL
6 0.0000133189 MYELOID DERIVED SUPPRESSOR CELLS//MDSC//MYELOID DERIVED SUPPRESSOR CELL
7 0.0000124043 FOXP3//TUMOR INFILTRATING LYMPHOCYTES//INTEGRAT CANC IMMUNOL
8 0.0000119048 WHOLE BLOOD CELL CULTURES//COLORIMETRY METHOD//HUMAN COLORECTAL TUMORS
9 0.0000115958 CCDC134//TUMOR IMMUN TOLERANCE SECT//ANTIGEN SPECIFIC CTL FUNCTION
10 0.0000091845 ADV CELL MOL THER Y//SHUNDE PEOPLES HOSP//TUMOR VACCINE